The Management of Co-Morbidities in Patients with Heart Failure – Angina and Coronary Disease
International Cardiovascular Forum Journal · 2017
DOI: 10.17987/icfj.v10i0.451 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Cardiovascular Forum Journal, 2017. Verfasst von Ilaria Spoletini und 1 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Co-morbidities are particularly relevant in the management of HF as they may confound HF diagnosis, worsen symptomatology, impact quality of life and aggravate the prognosis. According to the most recent European Society of Cardiology (ESC) guidelines, treatment of co- morbidities is an essential element of the comprehensive care of HF. Angina and coronary artery disease (CAD), in particular are common disorders associated with HF. The pharmacological and surgical management of angina according to the ESC guidelines is reviewed in this article.
Zitieren
APA
Spoletini, I., & Seferovic, P. (2017). The Management of Co-Morbidities in Patients with Heart Failure – Angina and Coronary Disease. International Cardiovascular Forum Journal. https://doi.org/10.17987/icfj.v10i0.451
Vancouver
Spoletini I, Seferovic P. The Management of Co-Morbidities in Patients with Heart Failure – Angina and Coronary Disease. International Cardiovascular Forum Journal. 2017. doi:10.17987/icfj.v10i0.451
BibTeX
@article{Spoletini2017,
author = {Spoletini, Ilaria and Seferovic, Petar},
title = {The Management of Co-Morbidities in Patients with Heart Failure – Angina and Coronary Disease},
journal = {International Cardiovascular Forum Journal},
year = {2017},
doi = {10.17987/icfj.v10i0.451}
}
EUVIMED